Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson’s disease

Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson’s disease

Show other versions (1)

There is ample epidemiological and animal-model evidence suggesting that intestinal inflammation is associated with the development of Parkinson’s disease (PD). Leucine-rich α2 glycoprotein (LRG) is a serum inflammatory biomarker used to monitor the activity of autoimmune diseases, including inflamm...

Full description

Bibliographic Details
Main Authors: Takuma Ohmichi, Takashi Kasai, Makiko Shinomoto, Fukiko Kitani-Morii, Yuzo Fujino, Kanako Menjo, Toshiki Mizuno
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946247/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946247/?tool=EBI

Similar Items